Cas:67633-96-9 3-Cis-Hexenyl Methyl Carbonate manufacturer & supplier

We serve Chemical Name:3-Cis-Hexenyl Methyl Carbonate CAS:67633-96-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Cis-Hexenyl Methyl Carbonate

Chemical Name:3-Cis-Hexenyl Methyl Carbonate
CAS.NO:67633-96-9
Synonyms:[(E)-hex-3-enyl] methyl carbonate
Molecular Formula:C8H14O3
Molecular Weight:158.19500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:184.8ºC at 760 mmHg
Density:0.964 g/cm3
Index of Refraction:1.433
PSA:35.53000
Exact Mass:158.09400
LogP:2.12570

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like [(E)-hex-3-enyl] methyl carbonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[(E)-hex-3-enyl] methyl carbonate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[(E)-hex-3-enyl] methyl carbonate Use and application,[(E)-hex-3-enyl] methyl carbonate technical grade,usp/ep/jp grade.


Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 3-Cis-Hexenyl Methyl Carbonate manufacturer The fine chemical industry includes fine chemicals and special chemicals. Fine chemical products have the characteristics of a small amount of production, relatively specific application fields, and long and complex industrial chains. They are mainly used in medicine, pesticides, dyes, liquid crystals and other fields. 3-Cis-Hexenyl Methyl Carbonate supplier Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 3-Cis-Hexenyl Methyl Carbonate vendor The move follows a Class I recall, the FDA’s most serious, launched by Innova in late April amid “significant concerns” about the test’s accuracy—and alongside an official warning letter delivered to the company this week. 3-Cis-Hexenyl Methyl Carbonate factory The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting.